BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 34369331)

  • 1. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.
    Wilkins JT; Hirschhorn LR; Gray EL; Wallia A; Carnethon M; Zembower TR; Ho J; DeYoung BJ; Zhu A; Rasmussen-Torvik LJ; Taiwo B; Evans CT
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1207-1215. PubMed ID: 34369331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study.
    Kohler P; Güsewell S; Seneghini M; Egger T; Leal O; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Ruetti M; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; Kuster SP; McGeer A; Risch L; Friedl A; Schlegel M; Vernazza P; Kahlert CR
    BMC Med; 2021 Oct; 19(1):270. PubMed ID: 34649585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers.
    Racine É; Boivin G; Longtin Y; McCormack D; Decaluwe H; Savard P; Cheng MP; Hamelin MÈ; Carbonneau J; Tadount F; Adams K; Bourdin B; Nantel S; Gilca V; Corbeil J; De Serres G; Quach-Thanh C
    Influenza Other Respir Viruses; 2022 Sep; 16(5):916-925. PubMed ID: 35510653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
    Mehboob S; Rehman A; Haq M; Rajab H; Haq M; Haq H; Ahmad J; Ahmad S; Abbas M; Anwar S; Haq N
    Ir J Med Sci; 2023 Apr; 192(2):915-918. PubMed ID: 35412213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.
    Iversen K; Kristensen JH; Hasselbalch RB; Pries-Heje M; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Sten C; Engel Møller ME; Benfield T; Ullum H; Jørgensen CS; Erikstrup C; Ostrowski SR; Nielsen SD; Bundgaard H
    Clin Microbiol Infect; 2022 May; 28(5):710-717. PubMed ID: 34543759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.
    Kiefer MK; Allen KD; Russo JR; Ma'ayeh M; Gee SE; Kniss D; Cackovic M; Costantine MM; Rood KM
    Am J Reprod Immunol; 2021 Dec; 86(6):e13490. PubMed ID: 34358389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.
    Johannesen CK; Rezahosseini O; Gybel-Brask M; Kristensen JH; Hasselbalch RB; Pries-Heje MM; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Jensen CAJ; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Dessau RB; Sørensen E; Harritshøj LH; Folke F; Sten C; Møller MEE; Engsig FN; Ullum H; Jørgensen CS; Ostrowski SR; Bundgaard H; Iversen KK; Fischer TK; Nielsen SD
    Microbiol Spectr; 2021 Oct; 9(2):e0090421. PubMed ID: 34668738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.
    Wack M; Péré H; Demory-Guinet N; Kassis-Chikhani N; Janot L; Vedie B; Izquierdo L; Bélec L; Veyer D
    J Clin Virol; 2021 Dec; 145():104999. PubMed ID: 34695725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol.
    Adeniyi OV; Stead D; Singata-Madliki M; Batting J; Hyera L; Jelliman E; Abrahams S; Parrish A
    Int J Environ Res Public Health; 2021 Jan; 18(1):. PubMed ID: 33466227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study.
    Mostafa A; Kandil S; El-Sayed MH; Girgis S; Hafez H; Yosef M; Saber S; Ezzelarab H; Ramadan M; Algohary E; Fahmy G; Afifi I; Hassan F; Elsayed S; Reda A; Fattuh D; Mahmoud A; Mansour A; Sabry M; Habeb P; Ebeid FS; Elanwar A; Saleh A; Mansour O; Omar A; El-Meteini M
    Int J Infect Dis; 2021 Mar; 104():534-542. PubMed ID: 33484863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
    PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
    Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
    Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.